Cargando…

Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis

Detalles Bibliográficos
Autores principales:	Bakker, D.S., Ariens, L.F.M., van Luijk, C., van der Schaft, J., Thijs, J.L., Schuttelaar, M.L.A., van Wijk, F., Knol, E.F., Balak, D.M.W., van Dijk, M.R., de Bruin‐Weller, M.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850107/ https://www.ncbi.nlm.nih.gov/pubmed/30597515 http://dx.doi.org/10.1111/bjd.17538

Ejemplares similares

Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study
por: Bakker, Daphne S., et al.
Publicado: (2021)

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry
por: ARIËNS, Lieneke F. M., et al.
Publicado: (2021)

Dupilumab facial redness: Positive effect of itraconazole
por: de Beer, Fleur S.A., et al.
Publicado: (2019)

Modulation of Conjunctival Goblet Cell Function by Inflammatory Cytokines
por: Contreras-Ruiz, L., et al.
Publicado: (2013)

Two‐year drug survival of dupilumab in a large cohort of difficult‐to‐treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry
por: Spekhorst, Lotte S., et al.
Publicado: (2020)

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease
por: Achten, Roselie, et al.
Publicado: (2023)

In vivo fluorescence imaging of conjunctival goblet cells
por: Kim, Seonghan, et al.
Publicado: (2019)

Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis
por: ACHTEN, Roselie E., et al.
Publicado: (2022)

EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
por: Bakker, Daphne S., et al.
Publicado: (2020)

The value of ongoing surveillance on the prevalence of contact sensitization
por: Schuttelaar, M.L.A.
Publicado: (2020)

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study
por: Oosterhaven, Jart A.F., et al.
Publicado: (2019)

The protective role of conjunctival goblet cell mucin sialylation
por: Matsuzawa, Moe, et al.
Publicado: (2023)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
por: Spekhorst, Lotte S., et al.
Publicado: (2023)

Responsiveness and interpretability of the Hand Eczema Severity Index
por: Oosterhaven, J.A.F., et al.
Publicado: (2019)

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry
por: Kamphuis, Esmé, et al.
Publicado: (2022)

Artificial Polymeric Scaffolds as Extracellular Matrix Substitutes for Autologous Conjunctival Goblet Cell Expansion
por: He, Min, et al.
Publicado: (2016)

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment
por: Bakker, Daphne S., et al.
Publicado: (2019)

Three cases of non‐atopic hyperkeratotic hand eczema treated with dupilumab
por: Loman, Laura, et al.
Publicado: (2020)

Immunocytochemical characterization of ex vivo cultured conjunctival explants; marker validation for the identification of squamous epithelial cells and goblet cells
por: Van Acker, Sara I., et al.
Publicado: (2023)

Validation of the Dutch Quality of Life in Hand Eczema Questionnaire (QOLHEQ)
por: Oosterhaven, J.A.F., et al.
Publicado: (2019)

Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy
por: Kato, Kumiko, et al.
Publicado: (2016)

Immunomodulatory Cross-Talk between Conjunctival Goblet Cells and Dendritic Cells
por: Contreras-Ruiz, Laura, et al.
Publicado: (2015)

Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic Mediators
por: García-Posadas, Laura, et al.
Publicado: (2018)

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro
por: Hansen, Pernille M., et al.
Publicado: (2022)

Ambient Levels of Air Pollution Induce Goblet-Cell Hyperplasia in Human Conjunctival Epithelium
por: Novaes, Priscila, et al.
Publicado: (2007)

Staphylococcus aureus Activates the NLRP3 Inflammasome in Human and Rat Conjunctival Goblet Cells
por: McGilligan, Victoria E., et al.
Publicado: (2013)

Inhibition of microRNA-328 Increases Ocular Mucin Expression and Conjunctival Goblet Cells
por: Choo, Jackson, et al.
Publicado: (2023)

The long‐term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis—52 week results from the Dutch BioDay Registry
por: Voorberg, Angelique N., et al.
Publicado: (2022)

Lipoxin A(4) Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells
por: Hodges, Robin R., et al.
Publicado: (2016)

Activation of the EGF Receptor by Histamine Receptor Subtypes Stimulates Mucin Secretion in Conjunctival Goblet Cells
por: He, Min, et al.
Publicado: (2018)

High expression of SARS-CoV-2 entry factors in human conjunctival goblet cells
por: Ma, Ruiqi, et al.
Publicado: (2021)

Sex-based differences in conjunctival goblet cell responses to pro-inflammatory and pro-resolving mediators
por: Yang, Menglu, et al.
Publicado: (2022)

Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
por: You, Yayan, et al.
Publicado: (2023)

Effects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitro
por: He, Hong, et al.
Publicado: (2010)

The effect of nerve growth factor on differentiation of corneal limbal epithelial cells to conjunctival goblet cells in vitro
por: Li, Weiwei, et al.
Publicado: (2010)

Lipoxin A(4) activates ALX/FPR2 Receptor to Regulate Conjunctival Goblet Cell Secretion
por: Hodges, Robin R., et al.
Publicado: (2016)

The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease
por: Simsek, Cem, et al.
Publicado: (2019)

Bioelectric Responses of Conjunctival Goblet Cells to Dry Eye: Impact of Ion Channels on Exocytotic Function and Viability
por: Puro, Donald G.
Publicado: (2020)

Conjunctival Goblet Cell Responses to TLR5 Engagement Promote Activation of Local Antigen-Presenting Cells
por: Logeswaran, Abiramy, et al.
Publicado: (2021)

Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis
por: Cohen, Victoria M. L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r9hcm6f2q0ha1hpf0mjtfpjjqo